S. Soh

Methods to reduce lipemic interference in clinical chemistry tests: a systematic review and recommendations

S. Sethi, T. P. Loh, Lizhen Ong, 2021, Clinical chemistry and laboratory medicine.

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.

P. Ng, Asif Javed, Y. Sia, 2020, Blood.

A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer

Jae Cheol Lee, Jih-Hsiang Lee, F. Siddiqui, 2017, Oncotarget.

Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia

A. Yeoh, L. Bendall, Su-Lin Lim, 2014, PloS one.

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

M. Nöthen, N. Nagarajan, T. Wong, 2012, Nature Medicine.

A novel BIM deletion polymorphism: implications and lessons for cancer targeted therapies.

S. Ong, S. Soh, 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology.